It is possible that the differential cytotoxic effects of various GnRH analogs on different cancer cells could be attributed to the different cellular environments and/or the diverse signaling pathways stimulated by divergent conformational states of GnRH-R, which are stabilized by various GnRH agonists [57,72,73,74]. Here, GNRH1 is linked to cancer.